Assessment of fixed‐duration therapies for treatment‐naïve <scp>Waldenström</scp> macroglobulinemia
Jithma P. Abeykoon(Mayo Clinic), Prashant Kapoor, Thomas E. Witzig(WinnMed), David Dingli, Jonas Paludo(WinnMed), Asher Chanan‐Khan(WinnMed), Francis K. Buadi, Morie A. Gertz(Medical University of South Carolina), Taimur Sher(Mayo Clinic in Florida), Rebecca L. King(Mayo Clinic in Arizona), Robert A. Kyle(Mayo Clinic), Carrie A. Thompson(Mayo Clinic), Thomas M. Habermann(Mayo Clinic in Arizona), Shaji Kumar(Mayo Clinic), Craig B. Reeder(Mayo Clinic in Arizona), Ronald S. Go(Mayo Clinic), Sikander Ailawadhi(Jacksonville College), Allison Rosenthal(Mayo Clinic Hospital), Stephen M. Ansell(Mayo Clinic), Grzegorz S. Nowakowski(Université Claude Bernard Lyon 1), S. Vincent Rajkumar(WinnMed), Wilson I. Gonsalves(Mayo Clinic in Arizona), David J. Inwards(Mayo Clinic), Patricia T. Greipp(Mayo Clinic), Saurabh Zanwar(Mayo Clinic), Martha Q. Lacy(Mayo Clinic), Eli Muchtar(Mayo Clinic), Rong He(Mayo Clinic), Gita Thanarajasingam(Mayo Clinic in Arizona), Angela Dispenzieri(Mayo Clinic), Vivek Roy(Jacksonville College), Jeremy T. Larsen(City of Hope)
Cited by 25
Related Papers
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
|New England Journal of Medicine|2014|3.5k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k